Blood panels
Quest and LabCorp draws at wholesale; you set retail and keep the margin.
Programs
Branded blood panels plus a genetic pathway report give your members a clear current-state picture and a long-term roadmap. Results inform the licensed provider.
$0 to start$0 until you're liveno cardcancel anytime
Wellstaq is a white-label clinical platform that lets labs & diagnostics offer labs, telehealth, 503A Rx and supplements under their own brand, while an independent, board-certified network licensed in all 50 states owns all clinical decisions and prescribing.
Your recurring upside
Start with your core program, then stack the layers you own. Drag the member count and toggle each layer — every figure is illustrative and set by you.
Your core membership program = membership, visits & monitoring.
Illustrative — you set your own pricing. Not a guarantee of earnings. Figures are your recurring program revenue (membership, monitoring, labs, supplements and adjacent care), not promised drug margin. Labs and supplements pass through at wholesale; you set retail and keep the margin. Wellstaq takes 0% of your sales.
At a $99/mo program,
just 21 members
cover your entire $2,000/mo platform fee. Every member after that is your margin.
Illustrative — you set your own pricing. Not a guarantee of earnings.
A proven model
Ro and Hims turned telehealth and recurring prescriptions into billion-dollar brands. You get that same model — plus blood labs, genetic reports and a branded supplement line they don't bundle — under your own name, with an independent 50-state network owning all clinical care.
Billion-dollar brands — built on years of venture capital.
Launch in weeks, for a flat fee — no raise required.
Members order panels and the genetic report through your app, in your brand.
Quest and LabCorp handle blood draws; the DNA test is a simple one-time collection.
Results inform a licensed provider, who owns any interpretation, evaluation, and prescribing.
Labs and diagnostics are the engine of a modern branded health business: bloodwork shows the current state, and a genetic pathway report adds a long-term roadmap, together making every other program more relevant. Wellstaq supplies both under your brand, with results informing an independent, board-certified network licensed in all 50 states that owns all interpretation and clinical decisions. You set retail on panels and the genetic report and keep that margin; the platform is a flat $2,000/mo, wholesale pass-through, zero percent of your sales.
14 pathways in the genetic report
Quest and LabCorp draws at wholesale; you set retail and keep the margin.
A one-time report mapping variants to pathways as a roadmap; you set retail and keep the margin.
Blood and DNA combined in your branded app to inform provider review.
Results processed through Quest, LabCorp, and CLIA-certified partner labs.
Licensed clinicians in all 50 states owning all interpretation and clinical decisions.
Quest + LabCorp
national lab coverage
A nationwide draw network and CLIA-certified processing mean your members can get tested almost anywhere, with the data feeding directly into provider-owned review.
You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.
How the economics work
$2,000/mo flat platform fee — the only cut we take. Blood labs, telehealth and supplements pass through at true wholesale cost; you set retail and keep the margin. Wellstaq takes 0% of your sales.
No. It is an educational, wellness roadmap that maps variants to pathways for discussion with a provider. It does not diagnose, prescribe, or determine which products anyone should use.
A licensed provider in the independent network owns all interpretation and any clinical decision. The data informs them; it does not replace them.
A flat $2,000/mo, wholesale pass-through, and 0% of your sales. Get on the list before spots open.
$0 to start$0 until you're liveno cardcancel anytime
Wellstaq provides technology and brand infrastructure. All clinical decisions, evaluations and prescribing are made by an independent, board-certified provider network licensed in all 50 states. Wellstaq and its partners make no diagnosis, treatment, efficacy or outcome claims; nothing here is medical advice.